UNASSIGNED: In 2013, approximately 179,000 bariatric surgery procedures were performed in the United States, including the laparoscopic sleeve gastrectomy (42.1%), Roux-en-Y gastric bypass (34.2%), and laparoscopic adjustable gastric banding (14.0%). Choice of procedure depends on the medical conditions of the @entity1 , @entity1 preference, and expertise of the surgeon. On average, weight loss of 60% to 70% of excess body weight is achieved in the short term, and up to 50% at 10 years. Remission of @entity6 occurs in 60% to 80% of @entity1 two years after surgery and persists in about 30% of @entity1 15 years after Roux-en-Y gastric bypass. Other @entity28 -related comorbidities are greatly reduced, and health-related quality of life improves. The Roux-en-Y procedure carries an increased risk of malabsorption sequelae, which can be minimized with nutritional supplementation and surveillance. Overall, these procedures have a mortality risk of less than 0.5%. Cohort studies show that bariatric surgery reduces all-cause mortality by 30% to 50% at seven to 15 years postsurgery compared with @entity1 with @entity28 who did not have surgery. Dietary changes, such as consuming protein first at every meal, and regular physical activity are critical for @entity1 success after bariatric surgery. The family physician is well positioned to counsel @entity1 about bariatric surgical options, the risks and benefits of surgery, and to provide long-term support and medical management postsurgery.

Treatment of XXXX with Bariatric Surgery.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity6 :: ('MESH:D003920', 'Disease') :: ['type 2 diabetes mellitus']
@entity28 :: (MESH:D009765,Disease) :: ['Adult Obesity']
